MAPT and stroke disorder: In normal conditions, the CSF expresses low levels of tau protein (up to 250–500 pg/mL), while tau concentration is elevated in neurological disorders characterized by ongoing neuronal and axonal degeneration, such as CJD, stroke, and encephalitis.